StockNews.com lowered shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) from a strong-buy rating to a buy rating ...
Ever heard of the “January effect?” In case you haven’t, a “January effect” is considered a phenomenon in the stock market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback